Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.

Norbert J Tripolt; Felix Aberer; Regina Riedl; Jasmin Url; Gudrun Dimsity; Andreas Meinitzer; Tatjana Stojakovic; Faisal Aziz; Ronald Hödl; Gabriele Brachtl; Dirk Strunk; Marianne Brodmann; Franz Hafner; Harald Sourij

doi:10.1186/s12933-018-0716-x

Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.

Norbert J Tripolt
, Felix Aberer
, Regina Riedl
, Jasmin Url
, Gudrun Dimsity
, Andreas Meinitzer
, Tatjana Stojakovic
, Faisal Aziz
, Ronald Hödl
, Gabriele Brachtl (Co-Autor/-in)
, Dirk Strunk (Co-Autor/-in)
, Marianne Brodmann
, Franz Hafner
, Harald Sourij

Universitätsinstitut für experimentelle und klinische Zelltherapie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

15 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	71
Fachzeitschrift	CARDIOVASCULAR DIABETOLOGY
Jahrgang	17
Ausgabenummer	1
DOIs	https://doi.org/10.1186/s12933-018-0716-x
Publikationsstatus	Veröffentlicht - 2018

Zugriff auf Dokument

10.1186/s12933-018-0716-x

Dieses zitieren

Tripolt, N. J., Aberer, F., Riedl, R., Url, J., Dimsity, G., Meinitzer, A., Stojakovic, T., Aziz, F., Hödl, R., Brachtl, G., Strunk, D., Brodmann, M., Hafner, F., & Sourij, H. (2018). Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial. CARDIOVASCULAR DIABETOLOGY, 17(1), 71. https://doi.org/10.1186/s12933-018-0716-x

@article{0c5e34b0d31f4c6187bb9805b92aa507,

title = "Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.",

author = "Tripolt, \{Norbert J\} and Felix Aberer and Regina Riedl and Jasmin Url and Gudrun Dimsity and Andreas Meinitzer and Tatjana Stojakovic and Faisal Aziz and Ronald H{\"o}dl and Gabriele Brachtl and Dirk Strunk and Marianne Brodmann and Franz Hafner and Harald Sourij",

note = "Brachtl, Strunk: Paracelsus Private Med Univ, Spinal Cord \& Tissue Regenerat Ctr Salzburg, Expt \& Clin Cell Therapy Inst, Salzburg, Austria; ",

year = "2018",

doi = "10.1186/s12933-018-0716-x",

language = "English",

volume = "17",

pages = "71",

journal = "CARDIOVASCULAR DIABETOLOGY",

issn = "1475-2840",

publisher = " BioMed Central",

number = "1",

}

Tripolt, NJ, Aberer, F, Riedl, R, Url, J, Dimsity, G, Meinitzer, A, Stojakovic, T, Aziz, F, Hödl, R, Brachtl, G, Strunk, D, Brodmann, M, Hafner, F & Sourij, H 2018, 'Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.', CARDIOVASCULAR DIABETOLOGY, Jg. 17, Nr. 1, S. 71. https://doi.org/10.1186/s12933-018-0716-x

Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial. / Tripolt, Norbert J; Aberer, Felix; Riedl, Regina et al.
in: CARDIOVASCULAR DIABETOLOGY, Jahrgang 17, Nr. 1, 2018, S. 71.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.

AU - Tripolt, Norbert J

AU - Aberer, Felix

AU - Riedl, Regina

AU - Url, Jasmin

AU - Dimsity, Gudrun

AU - Meinitzer, Andreas

AU - Stojakovic, Tatjana

AU - Aziz, Faisal

AU - Hödl, Ronald

AU - Brachtl, Gabriele

AU - Strunk, Dirk

AU - Brodmann, Marianne

AU - Hafner, Franz

AU - Sourij, Harald

N1 - Brachtl, Strunk: Paracelsus Private Med Univ, Spinal Cord & Tissue Regenerat Ctr Salzburg, Expt & Clin Cell Therapy Inst, Salzburg, Austria;

PY - 2018

Y1 - 2018

U2 - 10.1186/s12933-018-0716-x

DO - 10.1186/s12933-018-0716-x

M3 - Original Article

C2 - 29773079

SN - 1475-2840

VL - 17

SP - 71

JO - CARDIOVASCULAR DIABETOLOGY

JF - CARDIOVASCULAR DIABETOLOGY

IS - 1

ER -